Progressions: A deep look at prostate cancer

Home
Archive
About
Meet the androgen receptor
Testosterone's cancer overlord
Nov 22, 2024 • 
Ben Nathanson
8
8

October 2024

Am I dying, or aren’t I?
How much to trust a medical test
Oct 21, 2024 • 
Ben Nathanson
6
4

December 2023

Hazard ratios clarified
An amendment to the previous post
Dec 9, 2023 • 
Ben Nathanson
It just don’t work on you
How to interpret a hazard ratio
Dec 6, 2023 • 
Ben Nathanson
4
5

April 2023

Genes? Chromosomes? DNA?
How they fit together
Apr 23, 2023 • 
Ben Nathanson
3
4

January 2023

Caught in the Akt
Trial drug capivasertib blocks a notorious cancer pathway
Jan 24, 2023 • 
Ben Nathanson
1
3

August 2022

Your tumor’s mug shot
Prostate cancer under the microscope
Aug 12, 2022 • 
Ben Nathanson
4
The gland you left behind
What your prostate did when it was doing what it was supposed to be doing
Aug 10, 2022 • 
Ben Nathanson
6
4

June 2022

Down-to-earth microsatellite instability
What it is, what it means, and what's with the name
Jun 17, 2022 • 
Ben Nathanson
1

May 2022

Show me the PSMA
Part 1 of a series on its who, what, when, and where
May 19, 2022 • 
Ben Nathanson
5
1
Where cancer gets the nerve
Professor Moriarty will see you now
May 7, 2022 • 
Ben Nathanson
5
2

April 2022

They call me vipivotide tetraxetan
How PSMA-617 got its new name
Apr 12, 2022 • 
Ben Nathanson
2
© 2025 Ben Nathanson
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture